Waiyan Yau - Bloomage BioTechnology Insider

Bloomage BioTechnology Corporation Limited -- Hong Kong Stock  

HKD 16.24  0.00  0.00%

Financial Controller

Mr. Yau Waiyan is NonExecutive Director of Bloomage BioTechnology Corporationrationration Limited. Mr. Yau is an associate member of the Hong Kong Institute of Certified Public Accountants
Age: 39  Executive Since 2016      
86 10 8567 0099  http://www.bloomagebio-tech.com
Yau graduated from the Hong Kong University of Science and Technology with a bachelor degree in professional accounting. Prior to joining the Company, Mr. Yau has worked for an international accounting firm for over 10 years.

Management Efficiency

The company has return on total asset (ROA) of 7.25 % which means that it generated profit of $7.25 on every $100 spent on asset. This is normal as compared to the sector avarege. Similarly, it shows return on equity (ROE) of 13.14 % meaning that it generated $13.14 on every $100 dollars invested by stockholders.
The company has accumulated 99.22 M in total debt with debt to equity ratio (D/E) of 39.4 indicating the company may have difficulties to generate enough cash to satisfy its financial obligations. Bloomage BioTechnology Corporation Limited has Current Ratio of 7.27 suggesting that it is liquid and has the ability to pay its financial obligations in time and when they become due.

Similar Executives

Entity Summary

Bloomage BioTechnology Corporationration Limited, an investment holding company, develops, manufactures, and sells biochemical solutions in the People?s Republic of China, Asia, the Americas, and internationally. Bloomage BioTechnology Corporation Limited (0963) is traded on Hong Kong Stock Exchange in Hong Kong. It is located in Jinan, and employs 758 people.

Did you try this?

Run Headlines Timeline Now

Headlines Timeline

Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity
Hide  View All  NextLaunch Headlines Timeline
Fix your portfolio
By capturing your risk tolerance and investment horizon Macroaxis technology of instant portfolio optimization will compute exactly how much risk is acceptable for your desired return expectations when you add Bloomage BioTechnology Corporation Limited to your portfolio

Top Management

Bloomage BioTechnology Leadership Team
Waiyan Yau, Executive
Wen Hai, Director
Lili Zhan, Director
Zhaofeng Xue, Director
Junhong Li, Director
Anmin Gong, CFO, MBA
Guixin Xu, Executive
Chunxi Wang, Executive
Ning Hu, Executive
Aihua Wang, Director
Xueping Guo, Director
Yihong Luan, Executive
Xuekun Jin, CEO
Ping Loong, Executive
Yan Zhao, Chairman
Jiajun Guo, Director
Aihua Liu, Director

Stock Performance

Bloomage BioTechnology Performance Indicators